Comparing the expression levels of ANGPTL4 mRNA between paired primary and recurred tumor tissues in 5 HCC patients, 4 recurred tumors (80%) were found to have significantly lower levels of ANGPTL4 mRNA than their matched primary tumors (Figure 1F). Here, ANGPTL4 is linked to hepatocellular carcinoma.